Simon M. Ametamey

8.3k citations

219 papers · 6.5k indexed · 1 hit paper · h-index 42

Radiology, Nuclear Medicine and Imaging top 0.5%
Molecular Biology top 5%
Cellular and Molecular Neuroscience top 0.5%
Organic Chemistry top 2%
Pharmaceutical Science top 0.2%

Co-authors: P. August Schubiger Michael Honer Roger Schibli Linjing Mu Alfred Buck Stefanie D. Krämer Valérie Treyer Matthias T. Wyss
Topics: Neuroscience and Neuropharmacology Research (80 papers)Radiopharmaceutical Chemistry and Applications (52 papers)Medical Imaging Techniques and Applications (44 papers)
Cited by: Pharmaceutical Science Biological Psychiatry Cellular and Molecular Neuroscience
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Angewandte Chemie International Edition
Partner nations: Switzerland Germany United States

In The Last Decade

Simon M. Ametamey

216 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Imaging with PET

2008 1.0k citations Simon M. Ametamey, Michael Honer et al. Chemical Reviews profile →

Peers

Countries citing papers authored by Simon M. Ametamey

Since Specialization

Citations

This map shows the geographic impact of Simon M. Ametamey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon M. Ametamey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon M. Ametamey more than expected).

Fields of papers citing papers by Simon M. Ametamey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon M. Ametamey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon M. Ametamey. The network helps show where Simon M. Ametamey may publish in the future.

Co-authorship network of co-authors of Simon M. Ametamey

This figure shows the co-authorship network connecting the top 25 collaborators of Simon M. Ametamey. A scholar is included among the top collaborators of Simon M. Ametamey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon M. Ametamey. Simon M. Ametamey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age- and sex-specific differences in myocardial sympathetic tone and left ventricular remodeling following myocardial injury 2025 ·Biology of Sex Differences ·Ahmed Haider,Susan Bengs,Angela Portmann,(unknown),(unknown),Monika Marędziak,Geoffrey Warnock,Alexander Akhmedov,Sebastian Kozerke,Claudia Keller,Fabrizio Montecucco,Bruno Weber,Linjing Mu,Ronny R. Buechel,Vera Regitz‐Zagrosek,Philipp A. Kaufmann,Giovanni G. Camici,Simon M. Ametamey,Cathérine Gebhard	0
2	Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density 2023 ·Translational Psychiatry ·(unknown),Lea M. Hulka,(unknown),Matthias Vonmoos,Katrin H. Preller,Valérie Treyer,Simon M. Ametamey,Markus R. Baumgartner,(unknown),Franziska Pahlisch,Cathrin Rohleder,F. Markus Leweke,Boris B. Quednow	7
3	Downstream Allosteric Modulation of NMDA Receptors by 3-Benzazepine Derivatives 2023 ·Molecular Neurobiology ·Nadine Ritter,(unknown),(unknown),(unknown),Julian A. Schreiber,Christoph Brenker,Timo Strünker,Dirk Schepmann,Thomas Budde,Nathalie Strutz‐Seebohm,Simon M. Ametamey,Bernhard Wünsch,Guiscard Seebohm	1
4	Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion 2023 ·Photoacoustics ·Ruiqing Ni,(unknown),(unknown),Xosé Luís Deán‐Ben,(unknown),Claudia Keller,Daniel Razansky,Simon M. Ametamey,Linjing Mu,César Nombela‐Arrieta,Jan Klohs	1
5	Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia 2020 ·Brain and Behavior ·Valérie Treyer,Anton Gietl,(unknown),(unknown),Rafael Meyer,Andreas Buchmann,Anass Johayem,Paul G. Unschuld,Roger M. Nitsch,Alfred Buck,Simon M. Ametamey,Christoph Höck	18
6	Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep–wake cycle 2019 ·SLEEP ·(unknown),Sebastian C. Holst,Valérie Treyer,Ruth Tuura,(unknown),Simon M. Ametamey,Alfred Buck,Hans‐Peter Landolt	30
7	Radiosynthesis and evaluation of an 18F–labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma 2018 ·EJNMMI Radiopharmacy and Chemistry ·(unknown),(unknown),Roger Schibli,Simon M. Ametamey,Martin Béhé	8
8	Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder 2018 ·Translational Psychiatry ·(unknown),Yoan Mihov,Valérie Treyer,Simon M. Ametamey,Anass Johayem,(unknown),Susanne Rösner,Alfred Buck,Gregor Hasler	36
9	Evaluation of¹¹C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk 2017 ·Journal of Nuclear Medicine ·Stefanie D. Krämer,(unknown),Linjing Mu,Ahmed Haider,Adrienne Müller Herde,(unknown),Claudia Keller,(unknown),Roger Schibli,Bernhard Wünsch,Simon M. Ametamey	32
10	A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5 2017 ·European Journal of Nuclear Medicine and Molecular Imaging ·Geoffrey Warnock,Michael Sommerauer,Linjing Mu,(unknown),(unknown),Valérie Treyer,Roger Schibli,Alfred Buck,Stefanie D. Krämer,Simon M. Ametamey	16
11	Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ 11 C]RS-016 targeting CB2 in atherosclerosis 2017 ·Nuclear Medicine and Biology ·(unknown),Roger Slavik,Linjing Mu,Zoran Rančić,Nicole Borel,Roger Schibli,Simon M. Ametamey,Stefanie D. Krämer,Adrienne Müller Herde	22
12	C-5 Hydroxyethyl and Hydroxypropyl Acyclonucleosides as Substrates for Thymidine Kinase of Herpes Simplex Virus Type 1 (HSV-1 TK): Syntheses and Biological Evaluation 2013 ·Molecules ·(unknown),(unknown),Ivana Novaković,(unknown),(unknown),(unknown),Simon M. Ametamey,Léonardo Scapozza,Silvana Raić‐Malić	8
13	Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques 2013 ·PubMed ·Cindy R. Fischer,Adrienne Müller,(unknown),Zoran Rančić,Philipp A. Kaufmann,Roger Schibli,Simon M. Ametamey	3
14	Impact of inherent variability and experimental parameters on the reliability of small animal PET data 2012 ·EJNMMI Research ·(unknown),Simon M. Ametamey,(unknown),P. August Schubiger,Michael Honer	16
15	A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK) 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Ivana Novaković,Tatjana Gazivoda Kraljević,Sandra Kraljević Pavelić,Pero Lučin,(unknown),L. Pernot,Léonardo Scapozza,Simon M. Ametamey,Silvana Raić‐Malić	6
16	¹⁸F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors 2011 ·Journal of Nuclear Medicine ·Michael Honer,Linjing Mu,Timo Stellfeld,Keith Graham,Miljen Martić,Cindy R. Fischer,Lutz Lehmann,P. August Schubiger,Simon M. Ametamey,Ludger M. Dinkelborg,Ananth Srinivasan,Sandra Borkowski	55
17	Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands 2010 ·Bioorganic & Medicinal Chemistry ·(unknown),Linjing Mu,(unknown),Stefanie D. Krämer,Michael Honer,P. August Schubiger,Simon M. Ametamey	17
18	Molecular Imaging with PETbreakdown → 2008 ·Chemical Reviews ·Simon M. Ametamey,Michael Honer,P. August Schubiger	1016
19	SYNTHESIS AND IN VITRO AND IN VIVO EVALUATION OF [¹¹C]METHYL-BIII277CL FOR IMAGING THE PCP-BINDING SITE OF THE NMDA RECEPTOR BY PET 2002 ·Journal of Receptors and Signal Transduction ·(unknown),Michael Honer,(unknown),Matthias Grauert,P. August Schubiger,Simon M. Ametamey	11
20	123I-MSP and F[11C]MSP: New selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice 1998 ·Life Sciences ·Samuel Samnick,(unknown),Simon M. Ametamey,Jochen B. Bader,Wolfgang Brandau,Carl‐Martin Kirsch	5

About Simon M. Ametamey

Simon M. Ametamey is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science, having authored 219 papers that have together received 6.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (80 papers), Radiopharmaceutical Chemistry and Applications (52 papers) and Medical Imaging Techniques and Applications (44 papers). The work is most often cited by research in Pharmaceutical Science (773 citations), Biological Psychiatry (294 citations) and Cellular and Molecular Neuroscience (1.9k citations). Simon M. Ametamey has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include P. August Schubiger, Michael Honer, Roger Schibli, Linjing Mu, Alfred Buck, Stefanie D. Krämer, Valérie Treyer, Matthias T. Wyss, Adrienne Müller Herde and Cristina Müller. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact